I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

The anterior cruciate ligament (ACL) is one of major knee ligaments and is critical to knee stability. Injury to the ACL can be a debilitating musculoskeletal injury seen most often in athletes. The incidence of ACL injuries is currently estimated at approximately 200,000 in USA annually, with 100,000 ACL reconstructions performed each year.\[[@ref1][@ref2]\] In general, the incidence of ACL injury is higher in people who participate in high-risk sports, such as basketball, football, skiing, and soccer.\[[@ref3][@ref4][@ref5]\]

The goal of the ACL reconstruction surgery is to prevent instability and restore the function of the torn ligament, creating a stable knee so that the young can go back to the sporting activities. ACL reconstruction is uasually performed using either the patellar bone tendon and semitendinosis and gracilis tendons, and both are not free from complications. The most common is the graft failure and stretching of the graft due to delay in the tendon-bone healing and tendon-bone incorporation of a tendon-graft within the bone tunnel. Improvement of graft healing to bone is crucial to facilitate early and aggressive rehabilitation and a rapid return to full activity. To counteract this bone morphogenetic factors have been used with good results to improve the bone in growth in the tendon.\[[@ref6][@ref7]\] Anoka *et al*. (2012)\[[@ref8]\] reported a potential role of growth factors and bio-scaffolds for improving healing and mechanical integrity of the ACL injury that is reconstructed with a tendon-graft. It was shown that the use of a collagen-platelet-rich plasma scaffold stimulated healing of a defect in the canine ACL.\[[@ref9][@ref10]\]

Many other growth factors have been used in the early and better bone ingrowth at the site of ACL reconstruction with bone tendon-graft and tendon-graft.\[[@ref11][@ref12][@ref13][@ref14]\] Sadat-Habdan msenchymal stimulating peptide (SHMSP) was discovered at University of Dammam, Dammam and King Fahd Hospital of the University, AlKhobar and was patented in 2008 (United States Patency and Trade Office, US 7,399,826, B1 given on July 15, 2008). SHMP is a 13 amino acids with a molecular weight of 1460 KD, which is now available in the synthesized form. It was shown to stimulate bone growth and accelerate the healing of the fracture.\[[@ref15][@ref16]\] It was also shown to stimulate angiogenesis in a fracture module of healthy rabbits.\[[@ref17]\] A recent study showed that when topically applied there was early and better healing in diabetic animals.\[[@ref18]\]

The objective of this study is to assess the efficacy of a bone growth factor (SHMSP) in the rate of healing of bone tendon interface and osteo-integration of the tendon at the tunnel.

M[ETHODOLOGY]{.smallcaps} {#sec1-2}
=========================

The study was be carried out 20 skeletally mature male New Zealand rabbits. Rabbits were procured and were left in the animal house for 2 weeks for acclimatization to the surrounding. Under ketamine 50 ml/kg weight and xylazine 35 ml/kg weight animals were anesthetized. A 3 cm long lateral half of tendoachilles tendon of the left side was harvested and a bone tunnel was made in the region of ACL and a 1/0 ethilon suture was passed through the end of the harvested tendon \[[Figure 1](#F1){ref-type="fig"}\]. The tendon was place in the amorphous powder of the SHMSP as a growth factor at a dose of 5 ml/kg body weight A 2.5 mm drill hole was made at the ACL going between the tibia and the femur. The tendon was passed through the bony tunnel made and secured to each end of the tunnel with a 2/0 dexon \[Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}\]. In the control group, the procedure was repeated without the addition of the SHMSP. Both groups of animals were kept in the similar circumstances and monitored on a regular basis. After 4 weeks, 5 animals from each group were euthanized and 8 weeks the rest of the animals were euthanized. The lower limb was disarticulated at the hip joint and stored in 2% formalin at a temperature of 4°C and before histopathological analysis was done.

![Harvesting of the tendon](IJABMR-6-23-g001){#F1}

![Harvesting and drilling of the tendon](IJABMR-6-23-g002){#F2}

![Positioning of the tendon](IJABMR-6-23-g003){#F3}

The two groups were compared specifically for the bone in growth in the drill hole made at the tibial end through, which the tendon-graft was passed. The study was approved by the Institutional Review Board of the University of Dammam and funded by the Deanship of Scientific Research of University of Dammam, Saudi Arabia.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

There were no deaths in both the groups. One rabbit of the control group developed an infection. Figures [1](#F1){ref-type="fig"}--[4](#F4){ref-type="fig"} shows harvesting of the tendon, drilling, and position of the graft. In all the animals of the study group at 4 weeks showed, newly formed osteoid was observed at places early of the bone formation encroaching the tunnel, where in the control group tunnel was filled with the granulation tissue \[Figures [5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}\].

![Tendon in position](IJABMR-6-23-g004){#F4}

![Photomicrograph of control group at 4 weeks showing fibro-collagenous tissue (fibrosis); (H and E, ×40)](IJABMR-6-23-g005){#F5}

![Photomicrograph of study group at 4 weeks showing early bony exostosis in the tunnel; (H and E, ×40)](IJABMR-6-23-g006){#F6}

By 8 weeks in the study group, the canal was totally obliterated with increased mineralization of the new bone and at places seen extending onto the periosteal surface. In the control, there was minimal change in the formation of the new bone formation but there was more granulation tissue leading to form the connective tissue \[Figures [7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}\].

![Photomicrograph of control group at 8 weeks showing the whole tunnel is filled with granulation tissue with no signs of any new bone formation; (H and E, ×40)](IJABMR-6-23-g007){#F7}

![Photomicrograph of study group at 8 weeks showing abundant new bony formation and little granulation tissue in the tunnel; (H and E, ×40)](IJABMR-6-23-g008){#F8}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

Our study showed that in animals in which SHMSP was used to augment healing of the tendon-graft in the osseous tunnel there was exuberant bone formation, which was higher and more organized when compared to the control group of animals. The changes were subtle initially but 8 weeks the difference was more pronounced and appreciable. The histological specimens showed increased trabecular bone close to the grafted tendons as early as 4 weeks after implantation.

Different methods and growth factors were used to improve healing of the bone tendon interface. Rodeo *et al*.\[[@ref19]\] found that improved bone formation around a tendon-graft using recombinant human bone morphogenetic protein-2 (BMP-2) in an extra-articular bone tunnel in a dog model. Similarly, Nicklin *et al*.\[[@ref20]\] showed that exogenous osteogenic protein-1 results in improved bone formation at the tendon-bone interface in a sheep model. Recently, Pan *et al*.\[[@ref21]\] injected fibrin sealant (IFS) combined with BMP after ACL reconstruction showed that the rate of new bone formation of IFS-BMP composite was significantly and achieved a more prolonged osteogenic effect. Lim *et al*.\[[@ref14]\] coated mesenchymal stem cells to the tendon-graft thereby enhancing the of tendon-graft osteo-integration. In our study, we coated the tendon with the SHMSP to stimulate the osteo-integration in the tunnel with satisfactory results. In this study, we used SHMSP a small polypeptide, which was reported as an angiogenesis factor and showed results comparable to other growth factors.

The healing pattern between the tendon and the drill hole in the bone through which the tendon passes is not clearly understood but one this is certain that it takes many months probably to heal and incorporate and till that time certain activities are to be curtailed postsurgery.\[[@ref22][@ref23]\] For a young athlete to be away from sporting activities is quite difficult and early activity to jeopardize the repair causing up to 10,000 revision yearly of ACL reconstruction in the USA alone.\[[@ref24]\] If a osteo-integration of the bone -- tendon occurs early then recurrent injuries could be reduced. There is still no clinical evidence regarding the use of growth factors, due to the fact that dosage of these factors still remain undeterminable as most of the half-life of growth factors is too short to stimulate the healing for weeks. With regard to SHMSP which was used on a daily basis and a single dose proved the effect to be similar in fracture healing.\[[@ref15][@ref16]\]

We believe that our study has some limitations and the one which stands out that we did not perform bio-mechanical tests to assess the strength of the healing which was so convincing histologically and secondly a small sample of 10 animals on each side of the study arm.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

Our study shows that local application of SHMSP on the tendon-graft and instilling the growth factor in the tunnel itself enhanced the oseto-integration of the tendon into the bony tunnel created. We believe there is opportunity to convert this animal-based study into a clinical study when the safety of SHMSP is established.

Financial support and sponsorship {#sec2-1}
---------------------------------

Nil.

Conflicts of interest {#sec2-2}
---------------------

There are no conflicts of interest.

The authors sincerely thank the Deanship of Scientific Research, the University of Dammam for supporting this study with a grant no. 2012088, without this the study could not be completed.
